Publications & Works

Articles 27
All (27)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (25)
ESCI (2)
Scopus (24)
TRDizin (2)
Other Publications (2)
Papers Presented at Peer-Reviewed Scientific Conferences 27

1. Role of the AKT1 and CTNNB1 mutations in paclitaxel resistance

The 49th FEBS Congress, İstanbul, Turkey, 5 - 09 July 2025, pp.286, (Summary Text)

6. Investigation of MTHFR C677T gene polymorphism in patient with lung cancer.

Third International congress of Molecular Medicine, İstanbul, Turkey, pp.342, (Full Text) Sustainable Development

7. Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment

2nd Eurosia Biochemical Approaches and Technologies Congress, Antalya, Turkey, 26 - 29 October 2019, (Full Text) Sustainable Development

8. The cytotoxic effects of Ornithogalum oligophyllum and Ornithogalum umbellatum extracts

2nd Eurasian Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Turkey, 26 - 29 October 2019, pp.157, (Full Text) Sustainable Development

10. Antioxidant activities of Ornithogalum umbellatum

II. Eurasian Agriculture and Natural Sciences Congress, Baku, Azerbaijan, 11 - 15 September 2018, pp.130, (Full Text)

11. Antioxidant and in vitro enzyme inhibitory effects of Ornithogalum oligophyllum

2nd International Congress on Advances in Bioscience and Biotechnology (ICABB), Podgorica, Montenegro, 26 - 30 June 2018, pp.41, (Full Text)

12. Identification of the association between BHMT, CHDH and PEMT polymorphisms and rectal cancer in a Turkish population

2nd International Congress on Advances in Bioscience and Biotechnology (ICABB), Podgorica, Montenegro, 26 - 30 June 2018, pp.45, (Full Text) Sustainable Development

13. In vitro antioxidant, DNA protection capacities and cytotoxic activities of Allium kurtzianum extracts

The 21th International Congress Phytopharm 2017 and 10th Anniversary of the TCM Research Center Graz, Graz, Austria, 2 - 05 July 2017, vol.15, pp.71, (Full Text)

14. Helleborus vesicarius Aucher Bitkisinin Antioksidan ve Antikanser Aktiviteleri

22. Bİtkisel İlaç Hammaddeleri Toplantısı, Trabzon, Turkey, 31 August - 05 September 2016, pp.142, (Full Text)

16. Association of Polymorphisms in One Carbon Metabolism Genes with Lung Cancer in a Turkish Population

International Symposium on Advances in Predictive & Personalized Medicine, İstanbul, Turkey, 2 - 03 April 2015, pp.14, (Full Text) Sustainable Development

17. Investigation of association between paraoxonase-1 192/55 polymorphisms and serum paraoxonase activity in lung cancer

9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Turkey, 4 - 08 September 2010, vol.42, pp.263, (Summary Text) Sustainable Development

18. Degredation mechanisms responsible for decreased levels of a neutral endopeptidase (NEP) variant allozyme.

49th American Society of Cell Biology Meeting,, San Diego, United States Of America, 4 - 09 December 2009, pp.1, (Full Text)

20. Cytosolic, 5’-nucleotidase III (NT5C3) gene sequence variations and functional genomics

American Society of Clinical Pharmacology and Therapeutics Annual Meeting,, Washington, United States Of America, 19 - 22 March 2009, pp.47, (Full Text)

21. CYTOSOLIC 5 '-NUCLEOTIDASE III (NT5C3) GENE SEQUENCE VARIATION AND FUNCTIONAL GENOMICS: CYTOSINE ARABINOSIDE AND GEMCITABINE PHARMACOGENETICS

110th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, Maryland, United States Of America, 18 - 21 March 2009, vol.85

22. Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.

American Society of Clinical Pharmacology and Therapeutics Annual Meeting, Orlando, United States Of America, 2 - 05 April 2008, pp.18, (Full Text)

23. Gemcitabine pharmacogenomics: Deoxycytidine kinase (DCK) and cytidine monophosphate kinase (CMPK) gene sequence variation and functional genomics.

109th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, Florida, United States Of America, 2 - 05 April 2008, vol.83, (Summary Text)

24. NAD(P)H: Quinone Oxidoreductase Polymorphism and its Association to Lung Cancer in a Turkish Population

14 th IFCC-FE SCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, Czech Republic, 26 - 31 May 2001, pp.317, (Full Text) Sustainable Development

25. Lung Cancer Risk in Relation to Dopamine 2 Receptor Gene (DRD2)

14 th IFCC-FE SCC European Congress of Clinical Chemistry and Laboratory Medicine,, Prague, Czech Republic, 26 - 31 May 2001, pp.317, (Full Text) Sustainable Development

26. Identification of NAD(P)H: Quinone Oxidoreductase 609 C®T Polymorphism in a Turkish Population.

XVIth National Congress of Biochemistry. The Second International Bioscience Days, İzmir, Turkey, 23 - 27 October 2000, pp.17, (Full Text)

27. Dopamine D2 Receptor Gene (DRD2) Polymorphisms in a Turkish Population

4th Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries, Antalya, Turkey, 12 - 16 April 2000, pp.51, (Full Text)
Metrics

Publication

60

Publication (WoS)

28

Publication (Scopus)

24

Citation (WoS)

840

H-Index (WoS)

12

Citation (Scopus)

952

H-Index (Scopus)

12

Citation (Scholar)

86

H-Index (Scholar)

2

Project

40

Thesis Advisory

12

Open Access

29
UN Sustainable Development Goals